Forget Shell Stock, Pipeline ETF Pays 7.8% Yield This Year
A pipeline-focused ETF is drawing retirees with its steady monthly payouts, delivering roughly 7.8% annual yield and ...
When To Switch From Target Date Fund To Age Based Approach
When To Switch From Target Date Fund To Age Based Approach: Go. This intro covers when a switch makes sense and what signals to watch for in your plan.
25,368 articles
Compute Oil Emerges as Kalshi Launches AI Power Bets
Kalshi unveils a new prediction market to price future GPU computing power, positioning compute oil as a key asset cl...
Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
SEC Declares 'Most Crypto Assets' Clear Path for Investors
The SEC has moved to clarify which crypto assets fall under securities rules, saying that many assets—including staki...
Scott Bessent’s Treasury Department Takes on Defaulted Loans
The Treasury Department will assume management of about $180 billion in defaulted federal student loans, a decisive s...
Percent Owners Sell Million: Inside V2X Insider Moves
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
SpaceX IPO: Here's What Investors Should Watch Next
SpaceX could become one of the biggest IPOs in history. This guide breaks down what to watch, what it means for your ...
Netflix Ends Partnership with Meghan Markle Brand: Impacts
When a major streaming giant ends a brand partnership, the ripple effects reach creators, investors, and households. ...
Jerry Hall Says Mick: Blended Finances and Family Lessons
Celebrity stories can hide practical money lessons. This piece breaks down what we can learn from the way Jerry Hall ...
Morgan Stanley Files Amendments, Aims for Cheapest ETH SOL ETFs
Morgan Stanley filed amended SEC registrations for Ethereum and Solana ETFs, proposing a 14-basis-point sponsorship f...
Prediction: After Beating Last 15 Years, Vanguard Tops 2026
For more than a decade, one Vanguard ETF quietly outpaced the broad market. This article dives into why its growth ti...
Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status